Evidence map›Paper›PMID 31413085›Full record

ArticleHaematologica2020

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.

Zhaoming Li, Yue Song, Yanjie Zhang, Chaoping Li, Yingjun Wang, Weili Xue, Lisha Lu, Mengyuan Jin, Zhiyuan Zhou, Xinhua Wang and 20 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Types of T-cell lymphoma-a cytogenetic perspective.Annals of medicine and surgery (2012) · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 4 institutions in 2 countries.

Zhaoming LiDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yue SongDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yanjie ZhangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chaoping LiDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yingjun WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Weili XueDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lisha LuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengyuan JinDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhiyuan ZhouDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinhua WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ling LiDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lei ZhangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xin LiDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaorui FuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhenchang SunDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jingjing WuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xudong ZhangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hui YuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Feifei NanDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yu ChangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jiaqin YanDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaoyan FengDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaolong WuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Guannan WangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dandan ZhangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wencai LiDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Feixiang LiNovogene Bioinformatics Technology Co., Ltd., Xueqing Road, Beijing, China.
Yuan ZhangThe Academy of Medical Science of Zhengzhou University, Zhengzhou, China.
Ken H YoungDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mingzhi ZhangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China mingzhi_zhang1@163.com.
First Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CNNovogene Bioinformatics Institute · CNThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia-Lymphoma, Adult T-CellLymphoma, Non-HodgkinPrecursor T-Cell Lymphoblastic Leukemia-LymphomaAdultGenomicsHumansT-Lymphocytes

Identifiers

PMID31413085
PMCPMC7049353
OpenAlexW2968825245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.